Inhibiting KHSRP function could restore the expression of tumor suppressor genes, reduce epithelial-mesenchymal transition (EMT) and metastasis, and sensitize cancer cells to chemotherapy [35–37]. This evidence concerns the gene KHSRP and neoplasm.